Adiponectin Regulates Vascular Endothelial Growth Factor-C Expression in Macrophages via Syk-ERK Pathway

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Hu, Di ^a   Fukuhara, Atsunori ^a   Miyata, Yugo ^a   Yokoyama, Chieko ^a   Otsuki, Michio ^a   Kihara, Shinji ^a   Shimomura, Iichiro ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CYCLOOXYGENASE 2; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE SYK; TISSUE INHIBITOR OF METALLOPROTEINASE 1; VASCULOTROPIN C;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INDUCTION; HUMAN; HUMAN CELL; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; UPREGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR C GENE;

ADIPONECTIN; ANIMALS; CELL LINE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MACROPHAGES; MICE; NIACINAMIDE; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE KINASES; PYRIMIDINES; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 84873738842     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056071     Document Type: Article

References (28)

1. Shimomura I, Funahashi T, Takahashi M, Maeda K, Kotani K, et al. (1996) Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med 2: 800-803.
2. Matsuzawa Y, Funahashi T, Nakamura T, (1999) Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Ann N Y Acad Sci 892: 146-154.
3. Hotamisligil GS, Spiegelman BM, (1994) Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 43: 1271-1278.
4. Berg AH, Combs TP, Scherer PE, (2002) ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 13: 84-89.
5. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, et al. (1996) cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 221: 286-289.
6. Iwashima Y, Katsuya T, Ishikawa K, Ouchi N, Ohishi M, et al. (2004) Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 43: 1318-1323.
7. Chow WS, Cheung BM, Tso AW, Xu A, Wat NM, et al. (2007) Hypoadiponectinemia as a predictor for the development of hypertension: a 5-year prospective study. Hypertension 49: 1455-1461.
8. Machnik A, Neuhofer W, Jantsch J, Dahlmann A, Tammela T, et al. (2009) Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat Med 15: 545-552.
9. Ohashi K, Kihara S, Ouchi N, Kumada M, Fujita K, et al. (2006) Adiponectin replenishment ameliorates obesity-related hypertension. Hypertension 47: 1108-1116.
10. Kusunoki N, Kitahara K, Kojima F, Tanaka N, Kaneko K, et al. (2010) Adiponectin stimulates prostaglandin E(2) production in rheumatoid arthritis synovial fibroblasts. Arthritis and rheumatism 62: 1641-1650.
11. Kumada M, Kihara S, Ouchi N, Kobayashi H, Okamoto Y, et al. (2004) Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation 109: 2046-2049.
12. Awazawa M, Ueki K, Inabe K, Yamauchi T, Kubota N, et al. (2011) Adiponectin enhances insulin sensitivity by increasing hepatic IRS-2 expression via a macrophage-derived IL-6-dependent pathway. Cell Metab 13: 401-413.
13. Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A, et al. (2001) Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 103: 1057-1063.
14. Tsubakio-Yamamoto K, Matsuura F, Koseki M, Oku H, Sandoval JC, et al. (2008) Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages. Biochem Biophys Res Commun 375: 390-394.
15. Wijesekara N, Krishnamurthy M, Bhattacharjee A, Suhail A, Sweeney G, et al. (2010) Adiponectin-induced ERK and Akt phosphorylation protects against pancreatic beta cell apoptosis and increases insulin gene expression and secretion. J Biol Chem 285: 33623-33631.
16. Shibata S, Tada Y, Asano Y, Hau CS, Kato T, et al. (2012) Adiponectin Regulates Cutaneous Wound Healing by Promoting Keratinocyte Proliferation and Migration via the ERK Signaling Pathway. J Immunol 189: 3231-3241.
17. Riba R, Hughes CE, Graham A, Watson SP, Naseem KM, (2008) Globular adiponectin induces platelet activation through the collagen receptor GPVI-Fc receptor gamma chain complex. J Thromb Haemost 6: 1012-1020.
18. Bohmer R, Neuhaus B, Buhren S, Zhang D, Stehling M, et al. (2010) Regulation of developmental lymphangiogenesis by Syk(+) leukocytes. Dev Cell 18: 437-449.
19. Slack EC, Robinson MJ, Hernanz-Falcon P, Brown GD, Williams DL, et al. (2007) Syk-dependent ERK activation regulates IL-2 and IL-10 production by DC stimulated with zymosan. Eur J Immunol 37: 1600-1612.
20. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, et al. (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116: 1784-1792.
21. Kurosaki T, Takata M, Yamanashi Y, Inazu T, Taniguchi T, et al. (1994) Syk activation by the Src-family tyrosine kinase in the B cell receptor signaling. J Exp Med 179: 1725-1729.
22. Yokota T, Oritani K, Takahashi I, Ishikawa J, Matsuyama A, et al. (2000) Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 96: 1723-1732.
23. Okamoto Y, Folco EJ, Minami M, Wara AK, Feinberg MW, et al. (2008) Adiponectin inhibits the production of CXC receptor 3 chemokine ligands in macrophages and reduces T-lymphocyte recruitment in atherogenesis. Circ Res 102: 218-225.
24. Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, et al. (2001) Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7: 192-198.
25. Brakenhielm E, Veitonmaki N, Cao R, Kihara S, Matsuzawa Y, et al. (2004) Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci U S A 101: 2476-2481.
26. Mocsai A, Ruland J, Tybulewicz VL, (2010) The SYK tyrosine kinase: a crucial player in diverse biological functions. Nat Rev Immunol 10: 387-402.
27. Yamaguchi N, Argueta JG, Masuhiro Y, Kagishita M, Nonaka K, et al. (2005) Adiponectin inhibits Toll-like receptor family-induced signaling. FEBS Lett 579: 6821-6826.
28. Takemura Y, Ouchi N, Shibata R, Aprahamian T, Kirber MT, et al. (2007) Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies. J Clin Invest 117: 375-386.